News
Clinical Trials Arena on MSN1d
PYC Therapeutics to begin Part B in SAD trial for polycystic kidney diseaseP YC Therapeutics is set to begin Part B in its single ascending dose (SAD) study of the drug candidate, PYC-003, for ...
In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...
Bayer's big investment in time and money on the development of finerenone for chronic kidney disease (CKD) in diabetics has paid off with an FDA approval, although it could face stiff competition ...
US measles cases hit all-time high after disease was declared "eliminated" U.S. measles cases hit 1,277—the worst outbreak since the disease was declared eliminated in 2000, surpassing 2019's peak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback